Novartis to acquire inflammasome-focused IFM Tre

Tuesday, May 28, 2019 - 22:27 in Mathematics & Economics

The big company is bolstering its portfolio with 3 NLRP3 antagonists

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net